eli lilly sues compounders for selling unapproved copies of tirzepatide telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to Lilly Sues Four Compounders Over – TP Male Performance Burner | Size:12-Month Supply

eli lilly sues compounders for selling unapproved copies of tirzepatide telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to Lilly Sues Four Compounders Over – TP Male Performance Burner | Size:12-Month Supply

Male Performance Burner | GLP-1 Pathway Support + Fat Burner for Men | Helps Lose Weight, Maintain Muscle, Boost Energy | 3rd Party Tested Formula | 60 Unisex Weight Loss Pills

In a statement, Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, told the Guardian: “There’s no blind spot or loophole in FDA guidance that allows state-licensed compounding pharmacies to prepare copies of FDA-approved drugs when those drugs are in shortage.” He said: “It’s an intentional policy designed to assure patients don’t have to do without often life-saving medications when drugmakers can’t manage their supply chain

TP

Size:12-Month Supply

Rocky is far from the only company skirting these rules